Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Parkinson's Disease

  Free Subscription


1 Exp Brain Res
1 Exp Neurol
3 Mov Disord
1 Nat Rev Neurol
2 Neurology
1 Neurosci Lett
1 Neuroscience
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Exp Brain Res

  1. STEWART J, Bachman G, Cooper C, Liu L, et al
    Circadian dysfunction and fluctuations in gait initiation impairment in Parkinson's disease.
    Exp Brain Res. 2018 Jan 2. pii: 10.1007/s00221-017-5163.
    PubMed     Text format     Abstract available

    Exp Neurol

  2. LIMA JC, Oliveira LM, Botelho MT, Moreira TS, et al
    The involvement of the pathway connecting the substantia nigra, the periaqueductal gray matter and the retrotrapezoid nucleus in breathing control in a rat model of Parkinson's disease.
    Exp Neurol. 2018 Jan 3. pii: S0014-4886(18)30003.
    PubMed     Text format     Abstract available

    Mov Disord

  3. BLUMENFELD Z, Koop MM, Prieto TE, Shreve LA, et al
    Sixty-hertz stimulation improves bradykinesia and amplifies subthalamic low-frequency oscillations.
    Mov Disord. 2017;32:80-88.
    PubMed     Text format     Abstract available

  4. CHO H, Choi JY, Hwang MS, Lee SH, et al
    Subcortical (18) F-AV-1451 binding patterns in progressive supranuclear palsy.
    Mov Disord. 2017;32:134-140.
    PubMed     Text format     Abstract available

  5. VALSKY D, Marmor-Levin O, Deffains M, Eitan R, et al
    Stop! border ahead: Automatic detection of subthalamic exit during deep brain stimulation surgery.
    Mov Disord. 2017;32:70-79.
    PubMed     Text format     Abstract available

    Nat Rev Neurol

  6. MAETZLER W, Berg D
    Parkinson disease in 2017: Changing views after 200 years of Parkinson disease.
    Nat Rev Neurol. 2018 Jan 5. pii: nrneurol.2017.
    PubMed     Text format    


  7. FUJIMAKI M, Saiki S, Li Y, Kaga N, et al
    Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004888.
    PubMed     Text format     Abstract available

  8. MUNOZ DG, Fujioka S
    Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004898.
    PubMed     Text format    

    Neurosci Lett

  9. SEKAR S, Taghibiglou C
    Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.
    Neurosci Lett. 2017;666:139-143.
    PubMed     Text format     Abstract available


  10. NACKAERTS E, Michely J, Heremans E, Swinnen S, et al
    Being on target: visual information during writing affects effective connectivity in Parkinson's disease.
    Neuroscience. 2017 Dec 30. pii: S0306-4522(17)30917.
    PubMed     Text format     Abstract available

    PLoS One

  11. REKTOR I, Svatkova A, Vojtisek L, Zikmundova I, et al
    White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.
    PLoS One. 2018;13:e0187939.
    PubMed     Text format     Abstract available

  12. SHAO YM, Ma X, Paira P, Tan A, et al
    Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment.
    PLoS One. 2018;13:e0188212.
    PubMed     Text format     Abstract available

  13. YONEYAMA N, Watanabe H, Kawabata K, Bagarinao E, et al
    Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson's disease.
    PLoS One. 2018;13:e0190072.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.